Exponent Inc. reported its second-quarter 2025 earnings, revealing a slight increase in revenue, but a decline in stock price during aftermarket trading. The company posted earnings per share (EPS) of ...

Shares of scientific consulting firm Exponent (NASDAQ:EXPO) jumped in the afternoon session after UBS raised its price target on the company's stock to $81 from $76. The financial services firm kept a ...

Exponent Inc (NASDAQ:EXPO) delivered strong third-quarter results that exceeded analyst expectations, according to the company’s latest investor presentation. The engineering and scientific consulting ...

Exponent’s revenue has grown at a CAGR of 6% while EBITDA has at 8%. This has been driven by its fantastic business model and industry tailwinds. Exponent provides highly complex consulting services ...